Terms of Service

TERMS OF USE

Last Updated: July 29, 2026

SECTION 1: DEFINITIONS

For purposes of these Terms of Use (“Terms”), the following definitions shall apply:

1.1 Company: “Shefa Labs,” “we,” “our,” or “us” refers to Shefa Labs LLC, a Washington limited liability company (or its successor entity), the owner and operator of the AcuProHealth platform and all related commercial digital services.

1.2 Platform: “Platform” means the AcuProHealth proprietary software-as-a-service (SaaS) platform, including all associated websites, web applications, mobile applications, software architectures, source code, underlying databases, artificial intelligence features, advanced APIs, administrative dashboards, analytical reports, curated educational resources, and related technical services provided by Shefa Labs. The Platform explicitly includes, without limitation: Patient Care Plan Generator, Report of Findings Generator, Patient Snapshot Generator, Progress Tracking modules, Clinical Knowledge Base, AI-assisted clinical communication tools, clinical recommendation engine, Library Items, practice management tools, and any future software modules or upgrades released under the AcuProHealth brand.

1.3 User: A “User” means any authorized individual or commercial entity that accesses or uses the Platform. Users include licensed healthcare practitioners, acupuncturists, authorized clinic administrators, institutional staff members, enterprise account users, and authorized beta testers.

1.4 Practitioner: A “Practitioner” means an individual licensed healthcare professional who accesses or utilizes the Platform in connection with patient care, documentation, clinical communication, education, or practice management, and who remains solely accountable under their applicable professional license.

1.5 Patient: A “Patient” means any individual receiving professional healthcare, evaluation, or wellness services from a Practitioner. Patients are not third-party beneficiaries of this agreement, and nothing within these Terms creates any contractual, professional, or fiduciary relationship between Shefa Labs and any Patient.

1.6 Subscription: A “Subscription” means a paid commercial or promotional license granting a restricted, revocable right to access some or all features of the Platform during an active, defined billing period, subject to tiered seat limits and usage policies.

1.7 Services: “Services” refers collectively to all software, tools, automated functionalities, databases, artificial intelligence engines, updates, custom integrations, and technical support frameworks provided by Shefa Labs under an active Subscription.

1.8 Generated Content: “Generated Content” means any material, automated output, data synthesis, or documentation produced through the Platform, including content created wholly or partially through artificial intelligence systems, large language models, or automated algorithmic logic. This includes clinical summaries, Care Plans, Report of Findings documents, SOAP documentation, and lifestyle, exercise, or nutritional frameworks.

1.9 User Content: “User Content” means any raw data, documentation, clinical notes, patient symptoms, diagnoses, custom protocols, practice branding, text, files, images, or other materials uploaded, keyed, or submitted into the Platform by a User.

1.10 Artificial Intelligence (“AI”): “Artificial Intelligence” or “AI” refers to machine learning algorithms, large language models (LLMs), natural language processing tools, probabilistic recommendation engines, RAG (Retrieval-Augmented Generation) architectures, and rule-based systems utilized within the Platform to facilitate communication and aggregate reference data for Practitioners.

1.11 Knowledge Base: The “Knowledge Base” means the proprietary collection of clinical relationships, taxonomies, Traditional Chinese Medicine patterns, Western condition mappings, meridian and point datasets, system prompt architectures, prompt engineering methodologies, custom agent workflows, RAG vector embeddings, and organizational logic meticulously curated, owned, and developed by Shefa Labs.

1.12 Protected Health Information (“PHI”): “PHI” shall have the meaning ascribed to it under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), as amended, and its implementing regulations at 45 C.F.R. Parts 160 and 164.

SECTION 2: ACCEPTANCE OF TERMS & REGULATORY ALIGNMENT

2.1 Agreement to These Terms: These Terms constitute a legally binding commercial contract between you (the “User”) and Shefa Labs. Creating an account, purchasing a Subscription, clicking “I Agree,” or continuing to access the Platform establishes immediate, irrevocable acceptance of these Terms. If you do not accept these Terms in their entirety, you are strictly prohibited from accessing the Platform.

2.2 Electronic and Click-Wrap Enforcement: Electronic acceptance carries the exact legal force and validity of a handwritten signature. Shefa Labs reserves the right to employ interactive click-wrap validation frameworks for new features, material updates, or annual terms, ensuring robust evidentiary enforceability in any dispute.

2.3 Corporate & Institutional Authority: If you accept these Terms on behalf of a clinic, professional corporation, educational institution, hospital system, or partnership, you explicitly represent and warrant that you possess full legal corporate authority to bind that entity. If you lack such authority, you assume personal liability for any unauthorized platform utilization.

2.4 Unilateral Updates & Material Change Mechanisms: Shefa Labs may modify these Terms at any time to comply with changing healthcare regulations or operational architectures. We will provide thirty (30) days’ notice via the primary account email or conspicuous in-platform notification for any material changes. Continued utilization of the Platform following the conclusion of the 30-day notice period constitutes explicit acceptance. A User’s sole and exclusive remedy if they reject modifications is to cease use and request subscription cancellation prior to the effective date.

2.5 Integration of Policies & Business Associate Agreement (BAA): Incorporated into these Terms by reference are the Privacy Policy, AI & Clinical Disclaimer, and, where applicable, the executed Business Associate Agreement (“BAA”). In the event of an explicit conflict regarding data handling, the BAA shall govern strictly with respect to PHI; in all other operational or liability matters, these Terms shall control.

SECTION 3: ELIGIBILITY & PRACTITIONER COMPLIANCE MANDATES

3.1 Professional Licensing & Jurisdictional Standing: As an absolute condition of access, the User represents and warrants that they possess and actively maintain all valid, unrevoked state, provincial, or federal professional licenses, registrations, and certifications required to legally practice their profession within their jurisdiction. The User must immediately notify Shefa Labs if their professional license is suspended, restricted, or revoked, which will result in immediate suspension of account access.

3.2 Clinical Independence & Scope of Practice: The Platform is a commercial administrative tool and reference aggregator. It is not a licensed healthcare entity, does not practice medicine or acupuncture, and does not establish a clinical standard of care. The Practitioner represents and warrants that they will exercise independent professional judgment at all times and will never perform clinical actions or utilize Generated Content in a manner that exceeds their lawful scope of practice.

3.3 Security Mandates & Audit Rights: Users are strictly responsible for maintaining complex, unique credentials and securing administrative endpoints. Sharing single-practitioner credentials among multiple practitioners is a material violation of these Terms. Shefa Labs reserves the absolute right to programmatically monitor login concurrency, log API access, and conduct digital audits of account usage. Unauthorized license sharing triggers immediate suspension and retroactive billing at the standard multi-user/enterprise tier rate.

3.4 HIPAA Compliance and Data Entry Restrictions: User agrees and warrants that they shall enter, upload, or transmit Protected Health Information (“PHI”) only within the specific, designated secure clinical documentation modules of the Platform. User is strictly prohibited from entering PHI into general, non-encrypted feedback forms, prompt boxes not explicitly marked for clinical data entry, or customer support chat channels.

3.5 State Consumer Health Data & Biometric Law Compliance: User acknowledges that the Platform may collect data subject to state-specific consumer health data privacy laws (including, without limitation, the Washington My Health My Data Act, RCW 19.373, and its equivalents). User represents and warrants that it acts as the sole “Controller” of such data, and that it has provided all necessary conspicuous privacy notices and obtained all required explicit “opt-in” consents and audio/biometric permissions from individuals before transferring any consumer health data, voice recordings, images, or non-HIPAA regulated wellness information to the Platform.

3.6 Patient Identifiers & Non-HIPAA-Compliant Status: User acknowledges and agrees that, notwithstanding any other provision of these Terms, the Platform has not been independently certified or audited as HIPAA-compliant infrastructure. User shall not upload, publish, post, transmit, or otherwise expose any patient name, photograph, date of birth, medical record number, or other direct patient identifier through any Library Item, community-facing feature, testimonial, marketing material, or any other public-facing or shareable feature of the Platform. It is User’s sole responsibility to determine what, if anything, may safely be entered into the Platform in light of this Section and Section 3.4.

3.7 Sole Responsibility for Handouts, Digital Files & Patient Safety: User is solely responsible for independently reviewing every handout, digital file, worksheet, image, care plan, or other item of Generated Content – before it is given to a Patient, published, or shared anywhere else – to confirm it contains no patient identifier or PHI in violation of Section 3.6 and is safe and appropriate for the individual Patient. As between User and Shefa Labs, User bears sole and exclusive responsibility for any harm, injury, adverse reaction, or damage suffered by a Patient arising from or related to User’s use, modification, distribution, or publication of any such material. This obligation is in addition to, and does not limit, the review duties in Section 5.2, the liability exclusions in Section 6.3, and the indemnification obligations in Section 7.1.

SECTION 4: LICENSE GRANT, INTELLECTUAL PROPERTY & AI TRAINING RIGHTS

4.1 Limited License Grant: Subject to full compliance with these Terms and the timely payment of all applicable subscription fees, Shefa Labs grants the User a restricted, non-exclusive, non-transferable, non-sublicensable, revocable license to access and use the Platform solely for internal professional business and clinical support operations. No ownership rights or equity options are transferred under this agreement.

4.2 Rigorous License Restrictions: User shall not, and shall not permit any third party to:

(a) copy, modify, reverse engineer, decompile, or disassemble the Platform or its underlying source code;

(b) systematically scrape, harvest, extract, or mine data from the proprietary Knowledge Base;

(c) build a competing software platform, training framework, or clinical recommendation product utilizing any structural frameworks, prompt architectures, or datasets derived from the Platform;

(d) employ automated bots, spiders, or scripts to access or evaluate the Platform’s performance or speed; or

(e) engage in, attempt, or facilitate any “prompt injection” attacks, automated adversarial testing, jailbreaking, or structural manipulation designed to bypass the Platform’s safety filters, extract system prompts, expose the underlying Knowledge Base logic, or force the AI to generate non-compliant content. Any such attempt constitutes an immediate, non-curable material breach resulting in permanent account termination.

4.3 Ownership of User Content: As between the parties, the User retains exclusive ownership of all raw User Content submitted to the Platform, subject to the limited operational licenses granted herein to facilitate delivery of the Services.

4.4 Ownership of Knowledge Base & Platform IP: Shefa Labs retains exclusive and absolute ownership of all intellectual property rights, titles, and interests in the Platform, its software code, proprietary workflows, user interface designs, mathematical algorithms, prompt architecture, system prompts, agentic workflows, RAG vector databases, and the entire Knowledge Base, including all future iterations, enhancements, or derivatives thereof.

4.5 De-Identified Data Usage & AI Training License: Notwithstanding anything to the contrary herein, the User hereby grants to Shefa Labs a perpetual, irrevocable, worldwide, royalty-free, fully paid-up, transferable, and sublicensable license to aggregate, anonymize, and completely de-identify User Content and Generated Content (“De-Identified Data”) in strict compliance with the de-identification standards set forth under HIPAA (45 C.F.R. § 164.514(b)). Shefa Labs may utilize such De-Identified Data for any lawful commercial purpose, including but not limited to training, auditing, benchmarking, refining, and optimizing its machine learning models, large language models, predictive algorithms, and automated clinical reasoning architectures. This license survives the termination or expiration of these Terms indefinitely.

4.6 Non-Exclusivity of AI Generated Outputs: User acknowledges that due to the probabilistic nature of machine learning models, Generated Content produced for User may be similar or identical to content generated for other Practitioners. User acquires no exclusive ownership rights over any generic AI output, clinical synthesis template, or care plan structure generated by the Platform.

4.7 Algorithmic Disgorgement Indemnity & Model Isolation: User warrants that all User Content provided has been collected with all legally required patient consents and disclosures. In the event that any regulatory body or court orders a mandate of algorithmic disgorgement, model destruction, or model retraining against Shefa Labs due to a determination that User Content was collected or uploaded by User in violation of law, User shall be liable to Shefa Labs for the full replacement, engineering, and operational costs of retraining or rebuilding such models, alongside absolute indemnification for associated regulatory fines.

SECTION 5: AI GOVERNANCE & ABSOLUTE DISCLAIMER OF CLINICAL LIABILITY

5.1 Probabilistic Nature of Artificial Intelligence: The User explicitly acknowledges and agrees that the Platform utilizes advanced artificial intelligence systems, large language models, and rule-based software logic. These systems are inherently probabilistic and are fundamentally prone to structural limitations, including automated errors, data omissions, and inaccurate clinical syntheses commonly referred to as “hallucinations.” Generated Content is intended solely as an informational reference framework and communication drafting aid, and must never be relied upon as factually flawless or clinically definitive. GENERATED CONTENT DOES NOT CONSTITUTE A MEDICAL OR CLINICAL DIAGNOSIS AND IS NOT A SUBSTITUTE FOR THE PRACTITIONER’S OWN INDEPENDENT CLINICAL DIAGNOSIS, EVALUATION, OR JUDGMENT. THE PLATFORM DOES NOT DIAGNOSE, TREAT, OR MAKE TREATMENT DECISIONS FOR ANY PATIENT; ANY DIAGNOSIS OR TREATMENT DECISION REMAINS SOLELY AND EXCLUSIVELY THAT OF THE PRACTITIONER.

5.2 Mandatory Practitioner Review & Verification: The Practitioner bears an absolute, non-delegable legal and professional duty to carefully review, edit, verify, and approve all Generated Content before it is integrated into a patient record, utilized in a clinical setting, or shared with a Patient. This review must systematically confirm factual accuracy, safe dosages, valid contraindications, herbal-drug interactions, and clinical appropriateness for the specific patient’s profile. The Practitioner agrees to delete or correct any Generated Content that falls short of these standards.

5.3 Third-Party Beneficiary Waiver: The Platform is strictly a Business-to-Business (B2B) application. These Terms are intended solely for the benefit of the contracting parties. No Patient, client, or external third party is an intended or permitted third-party beneficiary under this agreement, and no such party shall have the legal right to enforce any provision herein or assert a claim against Shefa Labs arising from the clinical deployment of the software.

5.4 Statutory & Conspicuous Warranty Disclaimer: THE PLATFORM, SERVICES, KNOWLEDGE BASE, AND ALL GENERATED CONTENT ARE PROVIDED ENTIRELY ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SHEFA LABS EXPLICITLY DISCLAIMS ALL WARRANTIES, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT, DATA ACCURACY, AND SYSTEM SECURITY. SHEFA LABS DOES NOT WARRANT THAT THE PLATFORM WILL OPERATE UNINTERRUPTED, COMPLETELY SECURE, ERROR-FREE, OR THAT THE GENERATED CONTENT WILL COMPLY WITH PROFESSIONAL STANDARDS OF CARE OR REGULATORY CODES IN EVERY JURISDICTION.

SECTION 6: COMMERCIAL RISK ALLOCATION & LIMITATION OF LIABILITY

6.1 Complete Exclusion of Indirect and Consequential Damages: IN NO EVENT SHALL SHEFA LABS LLC, ITS SOLE MEMBER, INDIVIDUAL MANAGERS, OFFICERS, EMPLOYEES, AGENTS, OR LICENSORS BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES WHATSOEVER. THIS EXCLUSION INCLUDES, WITHOUT LIMITATION, DAMAGES FOR LOSS OF CLINICAL PROFITS, GOODWILL WAIVERS, DATA LOSS, COMPROMISED SYSTEM UPTIME, BUSINESS INTERRUPTION, OR PROCUREMENT OF SUBSTITUTE SERVICES, ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THE USE OF OR INABILITY TO USE THE PLATFORM, REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT PRODUCT LIABILITY, OR OTHERWISE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

6.2 Absolute Liability Cap: UNDER NO CIRCUMSTANCES SHALL THE TOTAL AGGREGATE LIABILITY OF SHEFA LABS LLC, ITS SOLE MEMBER, OR ITS MANAGERS TO THE USER FOR ANY AND ALL CLAIMS, DISPUTES, OR ACTIONS ARISING UNDER THESE TERMS OR UTILIZATION OF THE PLATFORM EXCEED THE ACTUAL TOTAL FEES PAID BY THE USER TO SHEFA LABS LLC DURING THE TWELVE (12) MONTH PERIOD IMMEDIATELY PRECEDING THE INCIDENT GIVING RISE TO SUCH LIABILITY. THIS CAP IS CUMULATIVE AND THE EXISTENCE OF MULTIPLE CLAIMS WILL NOT ENLARGE THIS LIMIT. THE PARTIES ACKNOWLEDGE THAT THIS CLAUSE REPRESENTS A FUNDAMENTAL RISK-ALLOCATION MECHANISM WITHOUT WHICH SHEFA LABS LLC COULD NOT VIABLY PROVIDE THE PLATFORM AT THE SUBSCRIPTION RATES OFFERED.

6.3 Exclusion of Malpractice and Bodily Injury Liability: SHEFA LABS ASSUMES ZERO LIABILITY FOR INDIVIDUAL PATIENT CARE, MEDICAL MALPRACTICE CLAIMS, MISDIAGNOSES, TREATMENT ERRORS, BODILY INJURY, OR WRONGFUL DEATH CLAIMS RESULTING FROM THE PRACTITIONER’S DEPLOYMENT, MISUSE, OR RELIANCE UPON GENERATED CONTENT OR CLINICAL RECOMMENDATIONS. CLINICAL ACCOUNTABILITY REMAINS EXCLUSIVELY AND UNCONDITIONALLY EXTANT WITH THE LICENSED PRACTITIONER.

6.4 Third-Party EHR and API Integration Disclaimer: TO THE EXTENT THE PLATFORM INTEGRATES WITH OR RELIES UPON THIRD-PARTY ELECTRONIC HEALTH RECORD (EHR) SYSTEMS, SCHEDULING SOFTWARE, OR EXTERNAL APIS, SHEFA LABS EXPLICITLY DISCLAIMS ALL LIABILITY FOR DATA SYNCHRONIZATION FAILURES, LATENCY, TRANSMISSION ERRORS, DATA CORRUPTION, OR SERVICE INTERRUPTIONS ORIGINATING WITHIN OR CAUSED BY SUCH THIRD-PARTY ARCHITECTURES. USER ASSUMES TOTAL OPERATIONAL RISK FOR MAINTAINING LOCAL BACKUPS OF ALL PATIENT DOCUMENTATION.

SECTION 7: USER INDEMNIFICATION

7.1 Indemnification Obligation: User agrees to defend, indemnify, and hold completely harmless Shefa Labs LLC, its sole member, individual equity owners, managers, officers, employees, agents, and licensors from and against any and all third-party claims, administrative enforcement actions, losses, liabilities, damages, judgments, settlement costs, fines, penalties, and legal expenses (including reasonable attorney’s fees) arising out of or relating to:

(a) User’s breach of any provision, warranty, representation, or covenant contained within these Terms;

(b) User’s negligent, reckless, or intentional misconduct in their professional practice;

(c) Any medical malpractice, bodily injury, or statutory consumer claims initiated by a Patient resulting directly or indirectly from the clinical use, modification, or sharing of Generated Content; or

(d) Any violation of state, federal, or international privacy laws, including unauthorized exposure of PHI within non-designated platform elements, or violations of HIPAA or state health privacy guidelines attributable to User endpoints.

SECTION 8: DISPUTE RESOLUTION & GOVERNING LAW

8.1 Governing Law & Forum Selection: These Terms, and any dispute or cause of action arising out of or relating to them, shall be governed by, construed, and enforced in accordance with the laws of the State of Washington, without giving effect to any principles of conflicts of law. The parties agree that any legal action or proceeding not subject to the arbitration clause herein shall be brought exclusively in the state or federal courts located in King County, Washington.

8.2 Mandatory Binding Arbitration: Any controversy, dispute, or claim arising out of or relating to these Terms, or the breach thereof, shall be settled by binding arbitration administered by the American Arbitration Association (“AAA”) in accordance with its Commercial Arbitration Rules. The place of arbitration shall be King County, Washington (or handled via remote video conference by mutual consent). The arbitration shall be conducted by a single neutral arbitrator with specialized experience in healthcare technology transactions. The arbitrator’s award shall be final and binding, and judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.

8.3 Class-Action Waiver: ALL CLAIMS AND DISPUTES WITHIN THE SCOPE OF THESE TERMS MUST BE ARBITRATED OR LITIGATED ON AN INDIVIDUAL BASIS AND NOT ON A CLASS, REPRESENTATIVE, OR COLLECTIVE BASIS. CLAIMS OF MORE THAN ONE USER OR PRACTITIONER CANNOT BE ARBITRATED OR LITIGATED JOINTLY OR CONSOLIDATED WITH THOSE OF ANY OTHER USER.

8.4 Mandatory Multi-Tiered De-Escalation and Executive Negotiation: Prior to initiating any formal arbitration proceeding, the parties agree to a mandatory thirty (30) day meet-and-confer period. The complaining party must submit a detailed written statement of dispute. Within fifteen (15) days of receipt, executive representatives from both Shefa Labs LLC and the User with full settlement authority must meet via video conference in a good-faith effort to resolve the dispute. The completion of this executive dispute negotiation window is an absolute condition precedent to filing any demand for arbitration.

SECTION 9: BILLING, SUBSCRIPTION RENEWAL & CANCELLATION

9.1 Recurring Monthly Billing: Subscription fees are billed on a recurring monthly cycle. The first billing charge occurs thirty (30) days after the date the User creates an account and enrolls in a Subscription (the “Anniversary Date”), and recurs automatically every thirty (30) days thereafter for as long as the Subscription remains active, charged to the payment method on file.

9.2 No Advance Renewal Reminders: User acknowledges and agrees that Shefa Labs is under no obligation to, and will not, send an advance reminder, notice, or other communication prior to each recurring monthly charge. By enrolling in a Subscription, User expressly consents to recurring automatic billing on each thirty (30) day Anniversary Date without further notice, and User is solely responsible for tracking their own billing cycle.

9.3 Continuous Billing Until Cancellation: The Subscription, and all recurring monthly charges associated with it, will continue indefinitely until affirmatively cancelled by the User in accordance with Section 9.4. Non-use of the Platform does not pause, suspend, or terminate billing.

9.4 Exclusive Cancellation Method: User may cancel their Subscription solely by initiating contact through the Platform’s designated “Contact Us” support messenger and requesting cancellation. Cancellation requests submitted by any other means (including, without limitation, email, phone, mail, or through a third-party payment processor) will not be recognized as valid and will not stop recurring billing. Cancellation takes effect at the end of the then-current thirty (30) day billing cycle in which the request is confirmed by Shefa Labs; it does not entitle User to a prorated or partial-cycle refund.

9.5 No Refunds; All Sales Final: ALL SUBSCRIPTION FEES AND CHARGES ARE NON-REFUNDABLE AND ALL SALES ARE FINAL. THIS APPLIES REGARDLESS OF THE REASON FOR CANCELLATION, THE LEVEL OR FREQUENCY OF USE OF THE PLATFORM DURING ANY BILLING CYCLE, DISSATISFACTION WITH THE SERVICES, OR EARLY TERMINATION, EXCEPT WHERE A REFUND IS EXPRESSLY REQUIRED BY APPLICABLE LAW.

9.6 Single-Clinic, Single-Concurrent-Practitioner License: Each Subscription is licensed for use by one (1) clinic entity, and permits only one (1) individual Practitioner to be logged in to and actively accessing the Platform under that Subscription at any given time. Additional concurrent Practitioner access requires a separate, additional Subscription or enterprise/multi-seat license purchased from Shefa Labs. This restriction is subject to the audit and concurrency-monitoring rights described in Section 3.3, and unauthorized concurrent or multi-clinic use will be treated as license sharing under that Section.

SECTION 10: MISCELLANEOUS PROVISIONS

10.1 Severability: If any provision of these Terms is held by a court or arbitrator of competent jurisdiction to be invalid, illegal, or unenforceable, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions of these Terms shall remain in full force and effect.

10.2 Entire Agreement: These Terms, together with the Privacy Policy, AI & Clinical Disclaimer, and any executed Business Associate Agreement (BAA) or Enterprise License Agreements, constitute the entire, integrated agreement between the User and Shefa Labs LLC regarding the subject matter hereof, superseding all prior or contemporaneous discussions, founder drafts, oral statements, or promotional marketing materials.

Shefa Labs LLC

d/b/a AcuProHealth

State of Organization: Washington, USA

Primary Dispute Venue: King County, Washington

© 2026 Shefa Labs LLC. All Rights Reserved.